DYRK1A inhibitors as potential therapeutics for β-cell regeneration for diabetes

K Kumar, C Suebsuwong, P Wang… - Journal of Medicinal …, 2021 - ACS Publications
According to the World Health Organization (WHO), 422 million people are suffering from
diabetes worldwide. Current diabetes therapies are focused on optimizing blood glucose …
被引用次数：58 相关文章

DYRK1A Inhibitors as Potential Therapeutics for β-Cell Regeneration for Diabetes

K Kumar, C Suebsuwong, P Wang… - Journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
According to the World Health Organization (WHO), 422 million people are suffering from
diabetes worldwide. Current diabetes therapies are focused on optimizing blood glucose …

[引用][C] DYRK1A Inhibitors as Potential Therapeutics for β-Cell Regeneration for Diabetes

K Kumar, C Suebsuwong, P Wang… - Journal of Medicinal …, 2021 - cir.nii.ac.jp
DYRK1A Inhibitors as Potential Therapeutics for β-Cell Regeneration for Diabetes | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

DYRK1A Inhibitors as Potential Therapeutics for β-Cell Regeneration for Diabetes.

K Kumar, C Suebsuwong, P Wang… - Journal of Medicinal …, 2021 - europepmc.org
According to the World Health Organization (WHO), 422 million people are suffering from
diabetes worldwide. Current diabetes therapies are focused on optimizing blood glucose …